{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# importing libraries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "from dotenv import load_dotenv\n",
    "load_dotenv()\n",
    "\n",
    "os.environ[\"OPENAI_API_KEY\"] = os.getenv(\"OPENAI_API_KEY\")\n",
    "os.environ[\"LANGCHAIN_API_KEY\"] = os.getenv(\"LANGCHAIN_API_KEY\")\n",
    "os.environ[\"LANGCHAIN_TRACING_V2\"] = \"True\"\n",
    "os.environ[\"LANGCHAIN_PROJECT\"] = os.getenv(\"LANGCHAIN_PROJECT\")\n",
    "os.environ[\"SURPER_API_KEY\"] = os.getenv(\"SURPER_API_KEY\")\n",
    "grok_api_key = os.getenv(\"GROQ_API_KEY\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\u001b[1m> Entering new AgentExecutor chain...\u001b[0m\n",
      "\u001b[32;1m\u001b[1;3mI need to analyze the clinical and histological details provided to arrive at a conclusion regarding the diagnosis indicated in the case of the 63-year-old female patient. \n",
      "\n",
      "Action: Research\n",
      "Action Input: \"dermatofibrosarcoma protuberans (DFSP) histology and clinical features\"\n",
      "\u001b[0m\n",
      "Observation: \u001b[36;1m\u001b[1;3mDermatofibrosarcoma protuberans (DFSP) is a rare type of skin cancer that originates from the fibroblasts in the dermis. It is characterized by a low-grade malignancy, but it has a propensity for local recurrence if not adequately excised. Below is an analysis of DFSP focusing on its histology and clinical features.\n",
      "\n",
      "### Clinical Features\n",
      "\n",
      "1. **Presentation**:\n",
      "   - DFSP typically presents as a slow-growing, firm, and nodular mass in the skin.\n",
      "   - Lesions are usually asymptomatic, but they can be tender or pruritic in some cases.\n",
      "   - The tumor can vary in color from skin-colored to reddish-brown and often has a sclerotic appearance.\n",
      "\n",
      "2. **Location**:\n",
      "   - DFSP most commonly occurs on the trunk (especially the back) and extremities, but it can appear anywhere on the body.\n",
      "\n",
      "3. **Demographics**:\n",
      "   - DFSP is more prevalent in adults, typically between the ages of 20 and 50 years.\n",
      "   - It has a slight male predominance and can occur in all ethnic groups.\n",
      "\n",
      "4. **Growth Pattern**:\n",
      "   - The tumor usually grows slowly over several years, sometimes presenting as a persistent, growing lesion that can be mistaken for a benign dermatological condition (e.g., keloids, lipomas).\n",
      "\n",
      "5. **Recurrence and Metastasis**:\n",
      "   - While DFSP has a low metastatic potential, it has a high rate of local recurrence (up to 50% if margins are not clear).\n",
      "   - Rarely, it can metastasize, particularly in cases that are poorly differentiated.\n",
      "\n",
      "### Histology\n",
      "\n",
      "1. **Microscopic Appearance**:\n",
      "   - DFSP is characterized by a proliferation of spindle-shaped fibroblasts in the dermis.\n",
      "   - The histological appearance shows a storiform (cartwheel) pattern of the tumor cells.\n",
      "   - The tumor infiltrates the subcutaneous tissue and may have a \"honeycomb\" appearance due to the interspersed collagen.\n",
      "\n",
      "2. **Cellular Features**:\n",
      "   - The spindle cells are pleomorphic and can exhibit mild atypia, but the mitotic activity is usually low.\n",
      "   - The stroma is often fibrous and can show varying degrees of myxoid change.\n",
      "\n",
      "3. **Immunohistochemistry**:\n",
      "   - DFSP is typically positive for CD34, which is a key finding that helps in differentiating it from other spindle cell tumors.\n",
      "   - It may also express BCL-2 protein.\n",
      "   - Other markers such as smooth muscle actin (SMA) and S100 are usually negative.\n",
      "\n",
      "4. **Genetic Features**:\n",
      "   - Many cases of DFSP are associated with a specific chromosomal alteration, particularly a translocation involving chromosomes 17 and 22, which leads to the formation of the COL1A1-PDGFB fusion gene.\n",
      "   - This genetic alteration plays a role in tumor pathogenesis and can serve as a target for specific therapies.\n",
      "\n",
      "### Diagnosis and Treatment\n",
      "\n",
      "- **Diagnosis**: Diagnosis is usually made through clinical examination and confirmed with a biopsy. The histopathological examination and immunohistochemical staining are crucial for a definitive diagnosis.\n",
      "  \n",
      "- **Treatment**: The primary treatment for DFSP is surgical excision with clear margins. Mohs micrographic surgery is often preferred due to the tumor's infiltrative nature, ensuring complete removal while preserving surrounding tissue.\n",
      "  \n",
      "- **Adjuvant Therapy**: In cases of recurrent disease or when margins are not clear, adjuvant therapies, including radiation therapy and targeted therapies (e.g., imatinib for cases with specific genetic alterations), may be considered.\n",
      "\n",
      "### Conclusion\n",
      "\n",
      "Dermatofibrosarcoma protuberans is a unique cutaneous tumor with distinct clinical and histological features. Its low-grade malignancy belies its propensity for local recurrence, making complete surgical excision crucial. Advances in understanding its molecular pathology are paving the way for targeted therapies, which may improve outcomes for patients with this challenging tumor. Regular follow-up is essential to monitor for recurrence or the development of metastasis.\u001b[0m\n",
      "Thought:\u001b[32;1m\u001b[1;3mI now know the final answer regarding the diagnosis indicated in the case of the 63-year-old female patient, which is dermatofibrosarcoma protuberans (DFSP), characterized by its specific clinical and histological features.\n",
      "\n",
      "Final Answer: The lesion in the patient is diagnosed as dermatofibrosarcoma protuberans (DFSP), based on the histological findings of spindle cell proliferation in a storiform pattern, moderate to marked atypia, infiltrative growth pattern, and clinical presentation of an elevated dermal mass with ulceration.\u001b[0m\n",
      "\n",
      "\u001b[1m> Finished chain.\u001b[0m\n",
      "\n",
      "\n",
      "\u001b[1m> Entering new AgentExecutor chain...\u001b[0m\n",
      "\u001b[32;1m\u001b[1;3mTo answer the question, I need to generate a comprehensive pathology report for the diagnosis of dermatofibrosarcoma protuberans (DFSP) based on the provided histological and clinical details. This will involve synthesizing the information into the structured format specified, including recommendations for further investigation.\n",
      "\n",
      "Action: Write\n",
      "Action Input: \n",
      "```\n",
      "1. **Patient Name (in Arabic)**: [not provided]\n",
      "2. **Patient Age**: [not provided]\n",
      "3. **Date Received**: [not provided]\n",
      "4. **Referring Doctor**: [not provided]\n",
      "\n",
      "### Clinical Data\n",
      "The patient presents with a dermal mass characterized by elevation and ulceration. The clinical presentation and histological findings suggest a diagnosis of dermatofibrosarcoma protuberans (DFSP). \n",
      "\n",
      "### Gross Examination\n",
      "The specimen is a skin lesion with measurements [not provided]. The mass exhibits an elevated, nodular appearance with areas of ulceration and discoloration. Precise measurements and further descriptions are required for a comprehensive assessment.\n",
      "\n",
      "### Microscopic Features\n",
      "Histological examination reveals a proliferation of spindle cells arranged in a storiform pattern. There is moderate to marked atypia and an infiltrative growth pattern into the subcutaneous tissue. Mitotic activity is observed, and the lesion displays characteristic features consistent with DFSP.\n",
      "\n",
      "### Diagnosis\n",
      "Dermatofibrosarcoma Protuberans (DFSP)\n",
      "\n",
      "### Comments\n",
      "The diagnosis of DFSP is supported by the histological findings of spindle cell proliferation in a storiform pattern and the clinical presentation of an elevated, ulcerated dermal mass. Differential diagnoses considered include malignant fibrous histiocytoma and neurofibroma; however, the infiltrative growth pattern and storiform arrangement support DFSP.\n",
      "\n",
      "### Recommendations\n",
      "- **Immunohistochemical Stains**: CD34 staining is recommended to confirm the diagnosis, as DFSP typically expresses CD34. \n",
      "- **Molecular Testing**: Consider testing for PDGFB rearrangement, which is often present in DFSP.\n",
      "- **Follow-Up**: Regular dermatological follow-up is advised to monitor for recurrence. Surgical excision with wide margins is the treatment of choice, and in cases of recurrence or unresectable tumors, targeted therapy with Imatinib may be considered.\n",
      "```\u001b[0m\n",
      "Observation: \u001b[36;1m\u001b[1;3m# Pathology Report\n",
      "\n",
      "## Patient Information\n",
      "1. **Patient Name (in Arabic)**: [not provided]\n",
      "2. **Patient Age**: [not provided]\n",
      "3. **Date Received**: [not provided]\n",
      "4. **Referring Doctor**: [not provided]\n",
      "\n",
      "---\n",
      "\n",
      "### Clinical Data\n",
      "The patient presents with a dermal mass characterized by elevation and ulceration. The clinical presentation and histological findings suggest a diagnosis of dermatofibrosarcoma protuberans (DFSP). \n",
      "\n",
      "### Gross Examination\n",
      "The specimen is a skin lesion with measurements [not provided]. The mass exhibits an elevated, nodular appearance with areas of ulceration and discoloration. Precise measurements and further descriptions are required for a comprehensive assessment.\n",
      "\n",
      "### Microscopic Features\n",
      "Histological examination reveals a proliferation of spindle cells arranged in a storiform pattern. There is moderate to marked atypia and an infiltrative growth pattern into the subcutaneous tissue. Mitotic activity is observed, and the lesion displays characteristic features consistent with DFSP.\n",
      "\n",
      "### Diagnosis\n",
      "Dermatofibrosarcoma Protuberans (DFSP)\n",
      "\n",
      "### Comments\n",
      "The diagnosis of DFSP is supported by the histological findings of spindle cell proliferation in a storiform pattern and the clinical presentation of an elevated, ulcerated dermal mass. Differential diagnoses considered include malignant fibrous histiocytoma and neurofibroma; however, the infiltrative growth pattern and storiform arrangement support DFSP.\n",
      "\n",
      "### Recommendations\n",
      "- **Immunohistochemical Stains**: CD34 staining is recommended to confirm the diagnosis, as DFSP typically expresses CD34. \n",
      "- **Molecular Testing**: Consider testing for PDGFB rearrangement, which is often present in DFSP.\n",
      "- **Follow-Up**: Regular dermatological follow-up is advised to monitor for recurrence. Surgical excision with wide margins is the treatment of choice, and in cases of recurrence or unresectable tumors, targeted therapy with Imatinib may be considered.\n",
      "\n",
      "---\n",
      "\n",
      "*This report is based on the provided clinical and histological data and should be interpreted in conjunction with the patient's clinical history and other diagnostic tests.*\u001b[0m\n",
      "Thought:\u001b[32;1m\u001b[1;3mI now know the final answer.\n",
      "\n",
      "Final Answer: A comprehensive pathology report for dermatofibrosarcoma protuberans (DFSP) has been generated, including clinical data, gross examination findings, microscopic features, diagnosis, comments, and recommendations for further testing and follow-up.\u001b[0m\n",
      "\n",
      "\u001b[1m> Finished chain.\u001b[0m\n",
      "A comprehensive pathology report for dermatofibrosarcoma protuberans (DFSP) has been generated, including clinical data, gross examination findings, microscopic features, diagnosis, comments, and recommendations for further testing and follow-up.\n"
     ]
    }
   ],
   "source": [
    "# from langchain.chat_models import ChatOpenAI\n",
    "# from langchain.agents import initialize_agent, AgentType\n",
    "# from langchain.tools import Tool\n",
    "# from langchain.prompts import PromptTemplate\n",
    "# from langchain.chains import LLMChain\n",
    "\n",
    "# # Create multiple agents with different roles\n",
    "# researcher = ChatOpenAI(temperature=0.7, model=\"gpt-4o-mini\")\n",
    "# writer = ChatOpenAI(temperature=0.5, model=\"gpt-4o\")\n",
    "\n",
    "# # Define tools for agents\n",
    "# def research_tool(query):\n",
    "#     return researcher.predict(f\"Research thoroughly: {query}\")\n",
    "\n",
    "# def writing_tool(input):\n",
    "#     return writer.predict(f\"Refine and polish: {input}\")\n",
    "\n",
    "# description1 = \"\"\"\n",
    "#  As a histopathology professional with over 30 years of experience and expertise in diagnosing pathology cases, you have extensive knowledge from reputable sources such as:\n",
    "\n",
    "# 1. College of American Pathologists (CAP) [CAP](https://www.cap.org/member-resources/pathology-careers/pathology-subspecialties/molecular-pathology)\n",
    "# 2. Diagnostic Histopathology Journal [Diagnostic Histopathology](https://www.diagnostichistopathology.co.uk/)\n",
    "# 3. Association for Molecular Pathology (AMP) [AMP](https://www.amp.org/)\n",
    "# 4. Histopathology Journal (Wiley Online Library) [Histopathology Journal](https://onlinelibrary.wiley.com/journal/13652559)\n",
    "# 5. Advances in Molecular Pathology (ScienceDirect) [Advances in Molecular Pathology](https://www.sciencedirect.com/journal/advances-in-molecular-pathology)\n",
    "# 6. Journal of Molecular Pathology (MDPI) [Journal of Molecular Pathology](https://www.mdpi.com/topics?journal=jmp&category=1)\n",
    "# 7. WebPath: The Internet Pathology Laboratory [WebPath](https://webpath.med.utah.edu/ORGAN.html)\n",
    "# 8. Osmosis [Osmosis](https://www.osmosis.org/library/md/foundational-sciences/anatomy)\n",
    "# 9. [Advances in Molecular Pathology (ScienceDirect)](https://www.sciencedirect.com/journal/advances-in-molecular-pathology)\n",
    "# This annual review publication covers current practices and latest developments in molecular pathology. It's a comprehensive source for staying updated on the field.\n",
    "# 10. [ScienceDirect Topics: Molecular Pathology and Histopathology](https://www.sciencedirect.com/browse/journals-and-books?contentType=JL&contentType=BK&contentType=TB&contentType=HB&contentType=RW&contentType=BS&accessType=openAccess)\n",
    "# These overview pages provide concise, expert-written summaries on molecular pathology and histopathology, offering quick access to foundational knowledge.\n",
    "\n",
    "# Your task is to analyze clinical and microscopic features to determine likely diagnoses, suggest special or immunohistochemical stains for confirmation, and provide a well-organized histopathology report.\n",
    "\n",
    "# When generating a pathology report, adhere to the following comprehensive guidelines to ensure a professional, accurate, and clinically relevant pathology report.\n",
    "\n",
    "# \"\"\"\n",
    "\n",
    "# # Create agents with specific tools\n",
    "# research_agent = initialize_agent(\n",
    "#     tools=[Tool(name=\"Research\", func=research_tool, description=description1)],\n",
    "#     llm=researcher,\n",
    "#     agent=AgentType.ZERO_SHOT_REACT_DESCRIPTION\n",
    "# )\n",
    "\n",
    "# description2 = \"\"\"\n",
    "# When generating a pathology report, adhere to the following comprehensive guidelines to ensure a professional, accurate, and clinically relevant pathology report.\n",
    "\n",
    "# **Report Structure:**\n",
    "\n",
    "# 1. **Patient Name (in Arabic)**\n",
    "# 2. **Patient Age**\n",
    "# 3. **Date Received**\n",
    "# 4. **Referring Doctor**\n",
    "\n",
    "# ### Followed by the main sections:\n",
    "\n",
    "# - **Clinical Data**: Summarize the patient's medical history, presenting symptoms, and any pertinent laboratory or imaging findings.\n",
    "# - **Gross Examination**: Provide a detailed description of the specimen's appearance, sizes, and any notable gross pathological features, ensuring all components are measured & described.\n",
    "# - **Microscopic Features**: Provide a thorough analysis of the histopathological findings, including descriptions of tissue architecture, cellular details, and essential criteria for grading and staging the disease, as well as any secondary pathological changes or complications.\n",
    "# - **Diagnosis**: Clearly articulate the primary diagnosis along with any secondary findings, ensuring consistency with the previously mentioned information and microscopic features. Accurately provide grading, staging, and any relevant disease subtypes and variants.\n",
    "# - **Comments**: Discuss briefly the rationale behind the diagnosis, addressing the relevant differential diagnoses, then the clinicopathological correlations, and the potential limitations of the current specimen type.\n",
    "# - **Recommendations**: Offer clear, actionable recommendations for further investigations, particularly IHC stains, to validate the diagnosis and exclude relevant differential diagnoses, and especially stains with prognostic or therapeutic implications.\n",
    "\n",
    "# Throughout the report, adhere to the latest College of American Pathologists (CAP) guidelines for histopathological reporting. If any critical information is missing, highlight this clearly in the relevant section as [not provided]. \n",
    "\n",
    "# For tumor grading and staging, refer to the latest World Health Organization (WHO) and CAP guidelines for the most current analysis.\n",
    "\n",
    "# Before submission, revise the entire report for spelling, grammar, and overall coherence. Ensure that the language maintains a professional tone while demonstrating high expertise and clinical relevance.\n",
    "\n",
    "# Adhering to these guidelines will result in a high-quality pathology report that clearly communicates essential findings and supports clinical decision-making.\n",
    "# \"\"\"\n",
    "# writing_agent = initialize_agent(\n",
    "#     tools=[Tool(name=\"Write\", func=writing_tool, description=description2)],\n",
    "#     llm=writer,\n",
    "#     agent=AgentType.ZERO_SHOT_REACT_DESCRIPTION\n",
    "# )\n",
    "\n",
    "# # Collaborative workflow\n",
    "# def multi_agent_workflow(initial_query):\n",
    "#     # Research phase\n",
    "#     research_result = research_agent.run(initial_query)\n",
    "    \n",
    "#     # Writing phase\n",
    "#     final_output = writing_agent.run(research_result)\n",
    "    \n",
    "#     return final_output\n",
    "\n",
    "# string = \"\"\"\n",
    "# The patient is a 63-year-old female who presented with an elevated dermal mass measuring approximately 3 x 3 cm, located on the back of the\n",
    "# lower thigh. The lesion has been present for two months and exhibits an indurated base with an ulcerated skin surface. Clinical features were\n",
    "# suspicious for malignancy, prompting an incisional biopsy of the skin and underlying dermal lesion.\n",
    "\n",
    "# The specimen consists of a wedge-shaped piece of skin and underlying tissue measuring\n",
    "# 1 cm in diameter and 2 cm in length. The specimen has been bisected and entirely\n",
    "# submitted for histological examination.\n",
    "\n",
    "# Histological examination reveals a dermal spindle cell proliferation extending\n",
    "# from the superficial dermis deep into the subcutaneous tissue. The lesion is\n",
    "# composed of nodular fascicles of spindle and stellate-shaped cells arranged in a\n",
    "# storiform pattern characteristic of dermatofibrosarcoma protuberans (DFSP).\n",
    "# The neoplastic cells demonstrate moderate to marked atypia, with many cells\n",
    "# exhibiting nuclear hyperchromasia, pleomorphism, and bizarre morphology. The\n",
    "# nuclei are elongated and wavy, with some showing prominent nucleoli. Mitotic\n",
    "# figures are present, including atypical forms, indicating a high proliferative index.\n",
    "# The tumor infiltrates the underlying subcutaneous fat in a distinctive honeycomb\n",
    "# or \"chicken wire\" pattern, where adipocytes are individually entrapped by the\n",
    "# neoplastic cells. This infiltrative growth pattern is a hallmark feature of DFSP.\n",
    "# Interspersed within the tumor are collagen bundles, which are often seen in DFSP\n",
    "# and contribute to its fibrosarcomatous appearance. The overlying epidermis\n",
    "# shows ulceration, consistent with the clinical presentation.\n",
    "# No definitive areas of conventional fibrosarcomatous transformation are\n",
    "# identified in the examined sections, which would be characterized by a\n",
    "# herringbone pattern and increased cellularity.\n",
    "# \"\"\"\n",
    "\n",
    "\n",
    "# # Example usage\n",
    "# result = multi_agent_workflow(string)\n",
    "# print(result)\n",
    "\n",
    "\n",
    "\n",
    "import os\n",
    "from langchain.chat_models import ChatOpenAI\n",
    "from langchain.agents import initialize_agent, AgentType\n",
    "from langchain.tools import Tool\n",
    "from langchain.prompts import PromptTemplate\n",
    "from langchain.memory import ConversationBufferMemory\n",
    "\n",
    "class PathologyReportWorkflow:\n",
    "    def __init__(self, api_key=None):\n",
    "        # API Key management\n",
    "        if api_key:\n",
    "            os.environ[\"OPENAI_API_KEY\"] = api_key\n",
    "        \n",
    "        # Initialize memory for context retention\n",
    "        self.memory = ConversationBufferMemory(memory_key=\"chat_history\")\n",
    "        \n",
    "        # Create specialized LLM agents\n",
    "        self.researcher = ChatOpenAI(\n",
    "            temperature=0.7, \n",
    "            model=\"gpt-4o-mini\", \n",
    "            max_tokens=2048\n",
    "        )\n",
    "        \n",
    "        self.writer = ChatOpenAI(\n",
    "            temperature=0.7, \n",
    "            model=\"gpt-4o\", \n",
    "            max_tokens=4096\n",
    "        )\n",
    "        \n",
    "        # Research agent description\n",
    "        research_description = \"\"\"\n",
    "     you are a histopathology professional with over 30 years of experience and expertise in diagnosing pathology cases\n",
    "       \n",
    "\n",
    "        \"\"\"\n",
    "        \n",
    "        # Writing agent description\n",
    "        writing_description = \"\"\"\n",
    "         you have extensive knowledge from reputable sources such as:\n",
    "            1. College of American Pathologists (CAP) [CAP](https://www.cap.org/member-resources/pathology-careers/pathology-subspecialties/molecular-pathology)\n",
    "            2. Diagnostic Histopathology Journal [Diagnostic Histopathology](https://www.diagnostichistopathology.co.uk/)\n",
    "            3. Association for Molecular Pathology (AMP) [AMP](https://www.amp.org/)\n",
    "            4. Histopathology Journal (Wiley Online Library) [Histopathology Journal](https://onlinelibrary.wiley.com/journal/13652559)\n",
    "            5. Advances in Molecular Pathology (ScienceDirect) [Advances in Molecular Pathology](https://www.sciencedirect.com/journal/advances-in-molecular-pathology)\n",
    "            6. Journal of Molecular Pathology (MDPI) [Journal of Molecular Pathology](https://www.mdpi.com/topics?journal=jmp&category=1)\n",
    "            7. WebPath: The Internet Pathology Laboratory [WebPath](https://webpath.med.utah.edu/ORGAN.html)\n",
    "            8. Osmosis [Osmosis](https://www.osmosis.org/library/md/foundational-sciences/anatomy)\n",
    "            9. [Advances in Molecular Pathology (ScienceDirect)](https://www.sciencedirect.com/journal/advances-in-molecular-pathology)\n",
    "            This annual review publication covers current practices and latest developments in molecular pathology. It's a comprehensive source for staying updated on the field.\n",
    "            10. [ScienceDirect Topics: Molecular Pathology and Histopathology](https://www.sciencedirect.com/browse/journals-and-books?contentType=JL&contentType=BK&contentType=TB&contentType=HB&contentType=RW&contentType=BS&accessType=openAccess)\n",
    "            These overview pages provide concise, expert-written summaries on molecular pathology and histopathology, offering quick access to foundational knowledge.\n",
    "\n",
    "            Your task is to analyze clinical and microscopic features to determine likely diagnoses, suggest special or immunohistochemical stains for confirmation, and provide a well-organized histopathology report.\n",
    "\n",
    "        When generating a pathology report, adhere to the following comprehensive guidelines to ensure a professional, accurate, and clinically relevant pathology report.\n",
    "\n",
    "        **Report Structure:**\n",
    "\n",
    "        1. **Patient Name (in Arabic)**\n",
    "        2. **Patient Age**\n",
    "        3. **Date Received**\n",
    "        4. **Referring Doctor**\n",
    "\n",
    "        ### Followed by the main sections:\n",
    "\n",
    "        - **Clinical Data**: Genrate the patient's medical history, presenting symptoms, and any pertinent laboratory or imaging findings.\n",
    "        - **Gross Examination**: Provide a detailed description of the specimen's appearance, sizes, and any notable gross pathological features, ensuring all components are measured & described.\n",
    "        - **Microscopic Features**: Provide a thorough analysis of the histopathological findings, including descriptions of tissue architecture, cellular details, and essential criteria for grading and staging the disease, as well as any secondary pathological changes or complications.\n",
    "        - **Diagnosis**: Clearly articulate the primary diagnosis along with any secondary findings, ensuring consistency with the previously mentioned information and microscopic features. Accurately provide grading, staging, and any relevant disease subtypes and variants.\n",
    "        - **Comments**: Discuss briefly the rationale behind the diagnosis, addressing the relevant differential diagnoses, then the clinicopathological correlations, and the potential limitations of the current specimen type.\n",
    "        - **Recommendations**: Offer clear, actionable recommendations for further investigations, particularly IHC stains, to validate the diagnosis and exclude relevant differential diagnoses, and especially stains with prognostic or therapeutic implications.\n",
    "\n",
    "        Throughout the report, adhere to the latest College of American Pathologists (CAP) guidelines for histopathological reporting. If any critical information is missing, highlight this clearly in the relevant section as [not provided]. \n",
    "\n",
    "        For tumor grading and staging, refer to the latest World Health Organization (WHO) and CAP guidelines for the most current analysis.\n",
    "\n",
    "        Before submission, revise the entire report for spelling, grammar, and overall coherence. Ensure that the language maintains a professional tone while demonstrating high expertise and clinical relevance.\n",
    "\n",
    "        Adhering to these guidelines will result in a high-quality pathology report that clearly communicates essential findings and supports clinical decision-making.\n",
    "        Genrate more details from the prev text for every section.\n",
    "\n",
    "      -  Clearly define the clinical context of the patient, including the tumor's location, size, and any associated symptoms.\n",
    "      -  Simplify the scientific language used in the report to make it more accessible for non-specialists or patients.\n",
    "      -  Include a detailed treatment plan that encompasses advanced options, such as targeted therapies (e.g., Imatinib) for unresectable or recurrent cases.\n",
    "      -  Add a discussion on potential differential diagnoses and their correlation with the described histopathological features.\n",
    "      -  Ensure integration of histological findings with clinical and radiological results to provide a comprehensive diagnostic picture.\n",
    "      -  Provide more detailed follow-up recommendations, specifying required tests and suggested intervals for monitoring\n",
    "        \"\"\"\n",
    "        \n",
    "        # Research tool\n",
    "        def research_tool(query):\n",
    "            return self.researcher.predict(f\"with details Analyze pathology case: {query}\")\n",
    "        \n",
    "        # Writing tool\n",
    "        def writing_tool(input):\n",
    "            return self.writer.predict(f\"Genrate pathology report: {input}\")\n",
    "        \n",
    "        # Initialize agents\n",
    "        self.research_agent = initialize_agent(\n",
    "            tools=[Tool(name=\"Research\", func=research_tool, description=research_description)],\n",
    "            llm=self.researcher,\n",
    "            agent=AgentType.ZERO_SHOT_REACT_DESCRIPTION,\n",
    "            memory=self.memory,\n",
    "            handle_parsing_errors=True,\n",
    "            verbose=True\n",
    "        )\n",
    "        \n",
    "        self.writing_agent = initialize_agent(\n",
    "            tools=[Tool(name=\"Write\", func=writing_tool, description=writing_description)],\n",
    "            llm=self.writer,\n",
    "            agent=AgentType.ZERO_SHOT_REACT_DESCRIPTION,\n",
    "            memory=self.memory,\n",
    "            handle_parsing_errors=True,\n",
    "            verbose=True\n",
    "        )\n",
    "    \n",
    "    def generate_report(self, clinical_data):\n",
    "        try:\n",
    "            # Research phase\n",
    "            research_result = self.research_agent.run(clinical_data)\n",
    "            \n",
    "            # Writing phase\n",
    "            final_report = self.writing_agent.run(research_result)\n",
    "            \n",
    "            return final_report\n",
    "        \n",
    "        except Exception as e:\n",
    "            return f\"Error generating report: {str(e)}\"\n",
    "\n",
    "# Example usage\n",
    "def main():\n",
    "    workflow = PathologyReportWorkflow()\n",
    "    \n",
    "    clinical_case = \"\"\"\n",
    "  The patient is a 63-year-old female who presented with an elevated dermal mass measuring approximately 3 x 3 cm, located on the back of the\n",
    "lower thigh. The lesion has been present for two months and exhibits an indurated base with an ulcerated skin surface. Clinical features were\n",
    "suspicious for malignancy, prompting an incisional biopsy of the skin and underlying dermal lesion.\n",
    "\n",
    "\n",
    "The specimen consists of a wedge-shaped piece of skin and underlying tissue measuring\n",
    "1 cm in diameter and 2 cm in length. The specimen has been bisected and entirely\n",
    "submitted for histological examination\n",
    "\n",
    "\n",
    "Histological examination reveals a dermal spindle cell proliferation extending\n",
    "from the superficial dermis deep into the subcutaneous tissue. The lesion is\n",
    "composed of nodular fascicles of spindle and stellate-shaped cells arranged in a\n",
    "storiform pattern characteristic of dermatofibrosarcoma protuberans (DFSP).\n",
    "The neoplastic cells demonstrate moderate to marked atypia, with many cells\n",
    "exhibiting nuclear hyperchromasia, pleomorphism, and bizarre morphology. The\n",
    "nuclei are elongated and wavy, with some showing prominent nucleoli. Mitotic\n",
    "figures are present, including atypical forms, indicating a high proliferative index.\n",
    "The tumor infiltrates the underlying subcutaneous fat in a distinctive honeycomb\n",
    "or \"chicken wire\" pattern, where adipocytes are individually entrapped by the\n",
    "neoplastic cells. This infiltrative growth pattern is a hallmark feature of DFSP.\n",
    "Interspersed within the tumor are collagen bundles, which are often seen in DFSP\n",
    "and contribute to its fibrosarcomatous appearance. The overlying epidermis\n",
    "shows ulceration, consistent with the clinical presentation.\n",
    "No definitive areas of conventional fibrosarcomatous transformation are\n",
    "identified in the examined sections, which would be characterized by a\n",
    "herringbone pattern and increased cellularity.\n",
    "\n",
    "DERMAL AND SUBCUTANEOUS SPINDLE CELL NEOPLASM WITH FEATURES HIGHLY SUGGESTIVE OF\n",
    "DERMATOFIBROSARCOMA PROTUBERANS (DFSP).\n",
    "    \"\"\"\n",
    "    \n",
    "    report = workflow.generate_report(clinical_case)\n",
    "    print(report)\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    main()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
